|
Model Number 5160-0000 |
Device Problem
Obstruction of Flow (2423)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 06/20/2023 |
Event Type
malfunction
|
Event Description
|
Livanova received a report that a tandemlife oxygenator abruptly experienced zero flow during support.Using super therapeutic anticoagulation, the user was initially able to achieve the 4.0lpm goal for patient blood flow, however this decreased to 2.5lpm within 5 minutes of support without changing the pump speed.The user attempted to troubleshoot by re-positioning the venous drainage cannula, which required a momentary pause of support.Upon re-initiating support, zero flow was able to be achieved via the circuit.A new circuit was primed and flow was initiated at appropriate flow.The replaced circuit was inspected for clotting but no thrombus was identified, though the oxygenator was unable to drain either by gravity or syringe suction.There was no patient impact reported.
|
|
Manufacturer Narrative
|
A1.-a6.Patient information was not provided.D4.The complained tandemlung oxygenator is a subcomponent of a kit.Udi provided in this report is for the kit the oxygenator was built into.H10.Livanova manufactures the tandemlife oxygenator.The incident occurred in tacoma, washington.There was no patient impact.A review of the dhr did not identify any deviations or non-conformities relevant to the reported issue.All tests and inspections were completed with passing results.A device evaluation is anticipated but has not yet begun, as the device has not yet been returned.If any additional information pertinent to the reported event is received, it will be provided in a supplemental report.
|
|
Manufacturer Narrative
|
The complained device was returned to livanova for evaluation.Visual inspection identified one area of biological deposit visible on bottom right of device close to inlet potting.A functional inspection was also performed.The oxygenator was connected to a circuit with a stock engineering pump and sterile water to collect pressure flow data.The hq tests performed, one with a stock engineering pump and the other with the returned pump, demonstrated pressure drops across the oxygenator which were comparable to a clean, stock oxygenator.There was no evidence found to suggest clot formation or any failure of the oxygenator returned for analysis, and there was no evidence to suggest any failure of the pump used in the case.As the reported issue could not be reproduced and no functional issues were identified with the oxygenator, a specific root cause was not determined and corrective actions were not identified.Based on the results of functional testing of the pump and oxygenator, it is considered unlikely that clot formation in either of those devices was the cause of reduced flow.It is unclear from the event report whether the cannula was swapped along with the pump and oxygenator during circuit exchange, and no cannula were returned for analysis.It is possible that a thrombus or other blockage formed in the cannula leading to the reduction in circuit flow.The failure to drain or force additional fluid through the oxygenator may have been caused by a vapor lock in the device or a clot that formed after blood had been sitting in the device after its removal from the support circuit.Static priming or draining of devices with gravity or syringe pressure is substantially more difficult after introduction and stasis of fluid within the device.Any clot could have deteriorated during return shipment or flow testing and therefore did not impact the hq tests performed during investigation.If any additional information pertinent to the reported event is received, it will be provided in a supplemental.
|
|
Search Alerts/Recalls
|
|
|